Cleared Traditional

K252228 - Seaman Pro/Seaman (FDA 510(k) Clearance)

Class II Hematology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K252228 · Checkcells, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2026
Decision
267d
Days
Class 2
Risk

K252228 is an FDA 510(k) clearance for the Seaman Pro/Seaman. Classified as Semen Analysis Device (product code POV), Class II - Special Controls.

Submitted by Checkcells, Inc. (Santa Monica, US). The FDA issued a Cleared decision on April 9, 2026 after a review of 267 days - an extended review cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Checkcells, Inc. devices

Submission Details

510(k) Number K252228 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 16, 2025
Decision Date April 09, 2026
Days to Decision 267 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
154d slower than avg
Panel avg: 113d · This submission: 267d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code POV Semen Analysis Device
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
Definition Device Used To Evaluate One Or More Human Semen Parameters Including Semen Volume, Sperm Concentration, Total Sperm Number, Sperm Motility, Sperm Morphology, Sperm Vitality, White Blood Cell Concentration, And Ph.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - POV Semen Analysis Device

All 27
Devices cleared under the same product code (POV) and FDA review panel - the closest regulatory comparables to K252228.
LensHooke X3 PRO Semen Quality Analyzer
K242830 · Bonraybio Co., Ltd. · May 2025
LensHooke X12 PRO Semen Analysis System
K242388 · Bonraybio Co., Ltd. · May 2025
SQA-iOw Sperm Quality Analyzer
K243114 · Medical Electronic Systems , Ltd. · May 2025
YO Home Sperm Test
K241628 · Medical Electronic Systems , Ltd. · Nov 2024